🟢 Damora Therapeutics is trading 5.3% up today, rebounding on improved risk sentiment

Damora Therapeutics is trading 5.3% up at $29.49, reversing last week’s pullback amid improving risk sentiment following softer June CPI inflation.

• The move comes despite a lack of fresh company-specific news or analyst action today, even as the broader healthcare sector trades lower.
• Shares appear to be recovering from recent volatility; the most recent corporate updates include July 1 equity inducement grants and ongoing pipeline progress.